GFAP and Huntington disease: Additionally, ns-scFv, unlike W20, did not affect the astrocytosis and microgliosis in the BACHD mice, W20 also did not affect the levels of GFAP and Iba-1 in WT mice (Supplementary Fig. 5), confirming the therapeutic specificity of W20 on HD mice.